PerkinElmer – Consensus Indicates Potential 12.2% Upside
PerkinElmer found using ticker (PKI) now have 11 analysts covering the stock with the consensus suggesting a rating of ''Hold''. The target price ranges between 202 and 149 calculating the average target price we see 173. Given that the stocks previous close was at 154.23 this would indicate that there is a potential upside of 12.2%. There is a 50 day moving average of 144.82 and the 200 day moving average is 166.66. The market capitalisation for the company is $19,456m. Find out more information at: https:||www.perkinelmer.com [stock_market_widget type="chart" template="basic" color="green" assets="PKI" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $21,824m based on the market concensus. PerkinElmer provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery Analytical Solutions and Diagnostics. The Discovery Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services.
PerkinElmer – Consensus Indicates Potential 12.2% Upside
PerkinElmer found using ticker (PKI) now have 11 analysts covering the stock with the consensus suggesting a rating of ''Hold''. The target price ranges between 202 and 149 calculating the average target price we see 173. Given that the stocks previous close was at 154.23 this would indicate that there is a potential upside of 12.2%. There is a 50 day moving average of 144.82 and the 200 day moving average is 166.66. The market capitalisation for the company is $19,456m. Find out more information at: https:||www.perkinelmer.com [stock_market_widget type="chart" template="basic" color="green" assets="PKI" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $21,824m based on the market concensus. PerkinElmer provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery Analytical Solutions and Diagnostics. The Discovery Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services.